MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, R. D.
Right arrow Articles by Sanders-Bush, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, R. D.
Right arrow Articles by Sanders-Bush, E.

Vol. 58, Issue 4, 859-862, October 2000

ACCELERATED COMMUNICATION
RNA Editing of the Human Serotonin 5-HT2C Receptor Delays Agonist-Stimulated Calcium Release

Raymond D. Price and Elaine Sanders-Bush

Departments of Pharmacology (R.D.P. and E.S.-B.) and Psychiatry (E.S.-B.) and the Center for Molecular Neuroscience (E.S.-B.), Vanderbilt University, Nashville, Tennessee

RNA encoding the human 5-HT2C receptor undergoes adenosine-to-inosine RNA editing events at five positions in the putative second intracellular loop, with a corresponding reduction in receptor/G-protein coupling. Agonist-stimulated calcium release was examined in NIH-3T3 fibroblasts stably expressing the nonedited human INI (hINI) or the edited hVSV or hVGV variants. We hypothesized that different receptor isoforms would show altered dynamics of agonist-induced calcium release. The three isoforms showed a rightward shift in agonist concentration-response curves for eliciting calcium release (EC50 values: hINI, 2.2 nM; hVSV, 15 nM; hVGV, 49 nM). Additionally, the hVGV receptor showed a blunted and delayed [Ca2+]i peak compared with the hINI or hVSV receptor isoforms. These distinctions in agonist-induced [Ca2+]i release imply that edited 5-HT2C receptors may produce distinct physiological responses within the central nervous system.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. McGrew, R. D. Price, E. Hackler, M. S. S. Chang, and E. Sanders-Bush
RNA Editing of the Human Serotonin 5-HT2C Receptor Disrupts Transactivation of the Small G-Protein RhoA
Mol. Pharmacol., January 1, 2004; 65(1): 252 - 256.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
E. Sanders-Bush, H. Fentress, and L. Hazelwood
Serotonin 5-HT2 Receptors: Molecular and Genomic Diversity
Mol. Interv., September 1, 2003; 3(6): 319 - 330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. D. Price, D. M. Weiner, M. S. S. Chang, and E. Sanders-Bush
RNA Editing of the Human Serotonin 5-HT2C Receptor Alters Receptor-mediated Activation of G13 Protein
J. Biol. Chem., November 21, 2001; 276(48): 44663 - 44668.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics